Preprint
Article

This version is not peer-reviewed.

Knowledge, Attitudes and Practices Regarding Influenza and Pertussis Immunization During Pregnancy in Greece

A peer-reviewed article of this preprint also exists.

Submitted:

07 February 2025

Posted:

11 February 2025

You are already at the latest version

Abstract

Background/ Objectives: Vaccination against influenza and pertussis in pregnant women protects mother and child through the transfer of protective antibo‐ dies across the placenta. However, pregnant women’s vaccine hesitancy is a major barrier to achieve satisfactory vaccination coverage in many developed countries. Methods: Greek pregnant women’s vaccination knowledge, attitudes, and practices were recorded. Sampling across country’s districts was applied to achieve geographic representativeness. Results: Questionnaires from 474 mothers were collected. Their mean age was 34 (±5) years. Vaccination uptake was 16.8% and 45.7%, for pertussis and influenza respectively. During their recent pregnancy, 68.9% and 27.1% of the responders had been informed by their gynecologists regarding influenza and pertussis maternal immunization, respectively, indicating that gynecologists miss to inform a significant rate of pregnant women. According to multiple logistic regression, women who gave birth during spring (OR: 2.29 vs. winter delivery, p=0.042) and those with an MSc or PhD (OR: 2.93 vs. school graduates, p=0.015) were more likely to receive influenza vaccination. Factors favoring influenza vaccination included doctorʹs recommendation (OR: 18.86, p<0.001), being not/somewhat afraid of potential vaccine side effects during pregnancy (OR: 2.09, p=0.012), considering flu as relatively/very dangerous during pregnancy (OR: 8.05, p<0.001), and flu vaccine as relatively/completely safe (OR: 4.37, p<0.001). Doctorʹs recommendation (OR: 29.55, p<0.001) and considering pertussis a relatively/very serious risk to the motherʹs health during pregnancy (OR: 6.00, p=0.002) were factors associated with pertussis vaccination during pregnancy. Conclusions: Education of both expectant mothers and obstetricians is urgently needed to increase immunization coverage during pregnancy. Low influenza vaccination coverage among women delivering during winter and low pertussis immunization rates, in combination with low recommendation rates for both vaccines strongly indicate that Greek obstetricians focus on maternal health alone. Their perspectives play an instrumental role in vaccine acceptance during pregnancy, shaping the immunization inclusion maps.

Keywords: 
;  ;  ;  ;  ;  

1. Introduction

Vaccination has successfully decreased mortality and morbidity of several vaccine preventable infectious diseases [1]. However, along with the significant public health benefit achievement, safety concerns have arisen, primarily due to the extensive use of media and other sources of information [2]. World Health Organization (WHO) defines vaccine hesitancy as an overall behavior influenced by factors related to 1) issues of trust, 2) questions of controversy (the value of the vaccine and the necessity of vaccination), and 3) access issues regarding vaccine delivery and vaccination systems [3,4].
Pregnant women's vaccination is an important tool for protecting fetal and neonatal health [5]. During pregnancy, maternal antibodies are transmitted to the fetus via the placenta, while secretory IgA antibodies are transferred to the infant through breastfeeding. The fetus, and later the newborn, is thus protected from life-threatening diseases during the first months of life, when both cellular and humoral immunity are weak, and infant immunization has not begun [6]. Notably, influenza vaccination is important for maternal health as well [7].
Pregnancy-related influenza vaccination recommendations have been in place since the 1960s, while the Centers for Disease Control and Prevention (CDC) advised for vaccination during pregnancy against tetanus, diphtheria, and acellular pertussis (Tdap) in 2011[8,9]. Both vaccines are regarded safe during pregnancy [10]. In the United States, coverage estimates for both vaccines are still below ideal levels despite CDC recommendations. [11,12] A recent overview of European policies on maternal immunization documents that several European nations, in accordance with WHO guidelines, have customized vaccination programs for expectant mothers [13]. However, the strategies used in different European countries and, consequently, the implementation efficacy vary.[13]
According to a recent international survey on vaccine refusal, Greece was ranked among the top 10 nations with the lowest rates of positive sentiment [14,15,16]. A study conducted in Western Greece in 2017 documented high awareness regarding influenza and pertussis among pregnant women. However, respondents lacked knowledge as far as respective vaccines, and their safety were concerned. [17]. Vaccination coverage rates among pregnant women in Greece have not been studied nationwide and remain grossly unknown since there is no national vaccination registry.
The aim of this study is to estimate vaccination coverage among Greek pregnant women in a stratified sample. Additionally, this study aspired to ascertain potential causes of inadequate vaccination and identify knowledge and awareness gaps among pregnant women.

2. Materials and Methods

A cross-sectional national study assessing the knowledge, attitudes, and practices [Knowledge, Attitude and Practices (KAP) study] of pregnant women was conducted between December 2020 and May 2022. Structured questionnaires were distributed to mothers of infants <12 months residing in Greece. Initially, a pilot study was conducted by distributing the questionnaires to 10 participants to assess the validity and internal consistency of the tool. Initially, a pilot study was conducted by distributing the questionnaires to ten participants to assess the validity and internal consistency of the tool. Following pilot study data processing, a question was removed, and the Cronbach’s alpha was calculated at 0.705 [18]. Sampling considering the geographically distributed administrative districts of the country as layers and pediatricians as clusters was carried out. For each pediatrician who was randomly selected, ten (10) mothers were asked to participate during the opening hours of their medical offices.

Statistical Analysis

The statistical analysis of the collected data was performed by the Center for Clinical Epidemiology and Outcomes Research (CLEO) in Athens. The sample size required was calculated considering the number of annual live births according to national registries (N=86550), the confidence level at 95%, the margin of error at 5% and the estimated maternal vaccination rate for influenza at 50%. Therefore, answers should be collected from 383 mothers who had recently given birth. Estimating that the response rate would be as high as 65%, questionnaires should be distributed to 590 mothers.
Categorical data are presented with absolute and relative (%) frequencies, while quantitative data are presented with mean, standard deviation (SD), median, interquartile range (IQR), minimum and maximum value. Normality of quantitative data was evaluated graphically with histograms. The X 2 test of independence, Fisher's exact test (where applicable), the independent samples t-test, and the non-parametric Mann-Whitney test were used to identify potential factors related to vaccination coverage of pregnant women against influenza and whooping cough. Multiple Logistic Regression was performed to assess the effect of these factors on pregnant women's vaccination coverage. The odds ratio (OR) along with the 95% confidence intervals (CI) were used to present the results. The statistical significance level was set at 5%. STATA SE v18 statistical software was used for the analysis.

Evaluation of Knowledge

Each mother's knowledge score was calculated based on responses given in 9 questions (min-max: 0-9). A score was determined only for the participants that had responded to all nine questions (Q3-Q11). The Appendix contains a description of the scoring procedure for each question. When the mother's knowledge score fell between 0 and 3, it was considered low; between 4-6, it was considered moderate; and between 7-9, it was considered high.

3. Results

Initially, 6 pediatricians working in 6 different public hospitals and 50 pediatricians across all geographic regions, working in private medical offices were recruited. Six hundred questionnaires were distributed. The response rate was higher than expected, with 474 mothers participating in the survey (response rate=79%). Table 1 depicts the demographics of the mothers who responded to questionnaire (N=474). Figure 1 describes maternal attitudes regarding influenza and pertussis vaccinations while Figure 2 depicts the level of trust among different sources of information on vaccine-related issues.

3.1. Influenza Maternal Vaccination

The reported rate of influenza vaccination during their index pregnancy was 45.7%. Most women declared that their gynecologist had informed them about the need to be vaccinated against influenza during their pregnancy (68.9%), and perceived that influenza is associated with risk to infants and themselves (89.2% and 71.1%, respectively). However, 29.2% considered influenza vaccination during pregnancy relatively/very dangerous. Out of 250 mothers who had an older child, only 70 (28%) had been vaccinated against influenza while being pregnant in their older child.
Non-vaccination was mainly attributed to lack of doctor’s recommendation (62.5%) and to the perception that pregnancy is not a risk factor for severe disease (34.2%). Nevertheless, 39.6% of mothers stated that it is likely to get vaccinated in a following pregnancy, while 25.7% that they would do so only after their Healthcare Practicioner’s (HCP’s) recommendation.
Factors associated with influenza vaccine uptake during pregnancy (crude logistic regression) were maternal age, nationality, education level, and occupation, as well as insurance type, season of labor, family status, and the HCP’s recommendation. The vaccination rates had also been impacted by maternal knowledge about influenza and her beliefs regarding the risks associated with diseases and vaccinations for expectant mothers and fetuses (Table 2).
Following multiple logistic regression, expectant mothers were more likely to be vaccinated if: a) their HCP’s recommended vaccination (OR: 18.86, 95% CI: 8.61-41.31, p<0.001); b) they were expected to give birth during spring compared to winter (OR: 2.29, 95% CI: 1.03-5.07, p=0.042); c) they were holding a PhD/MSc (OR: 2.93, 95% CI: 1.23-7.00, p=0.015); d) they considered influenza to be relatively dangerous/ very dangerous for mother’s health (OR: 8.05, 95% CI: 3.81-17.03, p=0.012); e) they considered influenza vaccine to be non-dangerous/relatively non-dangerous during pregnancy (OR: 4.37, 95% CI: 2.27-8.41, p<0.001); they were not/ a little afraid of possible vaccine side effects during pregnancy (OR: 2.09, 95% CI: 1.18-3.70, p=0.012).

3.2. Pertussis Maternal Vaccination

Maternal pertussis vaccination rate was 16.8% (78/474). Most women (72.9%) reported that they did not receive any relevant information from their HCPs. Many women perceived pertussis to be relatively dangerous/ very dangerous for pregnant women and for the infant (78.3% and 91% respectively). However, maternal pertussis vaccination was considered relatively/ very dangerous by 143 responders (30.6%). Among the multiparous mothers (N=250), the vast majority (233/247; 94.3%) reported absence of vaccination in their previous pregnancies. Table 3 depicts the results of the crude logistic regression, according to which, factors that were significantly associated with maternal pertussis vaccine uptake were parity, doctor’s recommendation, fear of vaccines’ adverse events, and considering whooping cough relatively dangerous/ very dangerous for the pregnant woman.

4. Discussion

This is the first study to document maternal knowledge, attitudes, and practices regarding influenza and pertussis vaccinations in Greece, in which a large sample was stratified among different geographical regions. It was conducted following the COVID-19 pandemic. Gkentzi et al. have also recorded the vaccine uptake during pregnancy in western Greece and have ended up to similar conclusions, highlighting the urgent need for education and awareness [17]. Results from the present cross-sectional study show that pregnant women's vaccination rates for pertussis and influenza are far below ideal. Primary causes identified include the absence of HCP’s recommendations and low maternal knowledge regarding both the risk of these infections for themselves and their offspring, and the effectiveness and safety of the relevant vaccination. Importantly, the overall low pertussis vaccine uptake and the low influenza vaccination rates among women who gave birth in winter show that, in Greece, obstetricians focus on maternal health and tend to overlook the importance of protecting the offspring as well.
Therefore, it is imperative to increase awareness on maternal vaccination among both obstetricians. and women of childbearing age. Additionally, midwives should be addressed as well, since they provide maternity care and have a significant impact on women's decisions regarding vaccinations [19,20]. A recording from Greece conducted by Taskou et al. highlights the crucial role HCPs have in the antenatal influenza immunization. Their role was even more significant during the SARS-CoV-2 pandemic, when the protection of public health and preventive measures implementation were of major importance [21]. The main challenge when addressing low vaccination acceptance among pregnant women is vaccine hesitancy, mainly attributed to the fear of possible vaccines’ adverse events for pregnant woman and the fetus. Therefore, there is an urgent need to empower both obstetricians and midwives through education, aiming to increase their confidence in advocating the efficacy and safety of maternal immunization and addressing women’s doubts and fears. [19,22,23]
As per influenza maternal vaccination, approximately half of the respondents reported that they got the vaccine during their recent pregnancy. Women who received a recommendation from their HCP were 18.86 times more likely to get vaccinated. A prior systematic review and meta-analysis that was published in 2020 concluded that pregnant women who received a recommendation from a health care professional were 10–12 times more likely to receive a pertussis or influenza vaccination. When individuals believed there was a possibility of vaccine-induced side effects, their likelihood of getting vaccinated was five times lower [24]. An Australian study found that women were 20 times more likely to get the influenza vaccine if a health care worker had recommended it to them [25,26]. Despite this, most HCPs worldwide continue to doubt maternal immunization, discouraging pregnant women from getting vaccinated [27]. These recordings and literature reviews emphasize how crucial it is to give medical professionals the knowledge and autonomy to clearly advise women and families [28,29].
Vaccination against pertussis in each pregnancy is recommended in most developed countries, given the fact that whooping cough has a significant rate of mortality and morbidity during infancy and maternal vaccination is the only tool to protect the most vulnerable young infants [30,31]. Importantly, recently there has been a significant increase of pertussis cases among infants in Europe, with higher morbidity and mortality rates to be documented in young infants [32]. In a recent systematic review, premature delivery. low maternal age. and lack of public insurance were identified as the key factors linked to low maternal pertussis vaccination acceptance [15]. Notably, HCPs' advice was important. since mothers who had received relevant information were significantly more likely to get vaccinated [15].
The main limitations of this KAP study concern participation bias. It is possible that respondents are more likely to be mothers with positive attitude towards vaccination. Similarly, the socioeconomic status of the responders constitutes another limitation. Despite efforts, illiterate women were underrepresented in this study. Unfortunately, the interviewers were not able to document demographic data from non-responders that would be helpful in depicting this kind of bias in our recording. Finally, vaccine uptake was not studied in association with pediatrician’s point of view. Pediatricians are healthcare providers who are familiar with vaccinations and may influence families’ practices. especially in cases of multiparous mothers.
Influenza and pertussis vaccine uptake during pregnancy remains low among Greek expectant mothers, mostly attributed to lack of HCP’s recommendations and suboptimal maternal awareness regarding the risks of these two diseases for maternal, fetal and neonatal health. Additionally, the efficacy and safety of the respective available vaccines are doubted by many pregnant women. Obstetricians are the main healthcare providers responsible for maternal health and thus their attitudes play a significant role in maternal immunization. Their education regarding vaccination during pregnancy needs to be consistent and targeted to increase vaccination rates among pregnant women and support the proper application of preventive medicine.

Supplementary Materials

The following supporting information can be downloaded at the website of this paper posted on Preprints.org. Table S1: Crude and Adjusted logistic regression regarding factors influencing antenatal immunization against both influenza and pertussis.

Author Contributions

Conceptualization, PG.M.. C.H., D.B., V.P.; Methodology, PG.M.. E.K.. D.K.. C.H.. A.D.. D.B., V.P..; Software, E.K.. D.K.; Validation, PG.M.. E.K.. D.K.. V.P..; Formal Analysis, PG.M.. E.K.. D.K.. V.P.; Investigation, PG.M.. V.P.; Resources, V.P.; Data Curation, E.K.. D.K.; Writing – Original Draft Preparation, PG.M.. E.K.. D.K.; Writing – Review & Editing, E.K.. D.K.. V.P.; Visualization, PG.M.. E.K.. D.K.. V.P.; Supervision, V.P..; Project Administration, PG.M.. V.P.

Funding

This research received no external funding.

Informed Consent Statement

A participant information sheet was given to each participant. Completing the questionnaire was intended to serve as simultaneous consent for participation.

Data Availability Statement

Data supporting reported results are available as anonymized databases upon request.

Acknowledgments

The contribution of all responders as well as of all doctors who participated in the distribution and collection of the questionnaires need to be acknowledged. The data processing and the statistical analysis was performed in Attikon University Hospital and in the Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO) in Athens. This article is a revised and expanded version of the presentation entitled "Influenza and pertussis immunization during pregnancy: is that "all Greek" to expectant mothers in Greece?”, which was presented at ESPID Research Masterclass, 42nd Annual Meeting of the European Society for Paediatric Infectious Diseases, Copenhagen, May 20-24, 2024.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

The following abbreviations are used in this manuscript:
WHO World Health Organization
CDC Centers for Disease Control and Prevention
Tdap tetanus, diphtheria, and acellular pertussis vaccine
KAP study Knowledge-Attitudes-Practices study
CLEO Collaborative Center for Clinical Epidemiology and Outcomes Research
SD Standard Deviation
OR Odds Ratio
CI Confidence Intervals
MSc Master of Science
PhD Doctor of Philosophy
HCP Healthcare practitioner/provider/professional
IQR Interquartile Range

References

  1. Orenstein WA, Douglas RG, Rodewald LE, Hinman AR. Immunizations in the United States: success, structure, and stress. Health affairs. 2005;24(3):599-610.
  2. Smith TC. Vaccine Rejection and Hesitancy: A Review and Call to Action. Open forum infectious diseases. 2017;4(3):ofx146.
  3. MacDonald NE, Hesitancy SWGoV. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33(34):4161-4.
  4. (SAGE SAGoE. meeting of the Strategic advisory group of experts on immunization, april 2014 – conclusions and recommendations. 2014.
  5. Marshall H, McMillan M, Andrews RM, Macartney K, Edwards K. Vaccines in pregnancy: The dual benefit for pregnant women and infants. Human vaccines & immunotherapeutics. 2016;12(4):848-56.
  6. Fouda GG, Martinez DR, Swamy GK, Permar SR. The Impact of IgG transplacental transfer on early life immunity. ImmunoHorizons. 2018;2(1):14-25.
  7. Regan AK, Munoz FM. Efficacy and safety of influenza vaccination during pregnancy: realizing the potential of maternal influenza immunization. Expert review of vaccines. 2021;20(6):649-60.
  8. Kennedy ED, Ahluwalia IB, Ding H, Lu PJ, Singleton JA, Bridges CB. Monitoring seasonal influenza vaccination coverage among pregnant women in the United States. American journal of obstetrics and gynecology. 2012;207(3 Suppl):S9-16.
  9. Centers for Disease C, Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morbidity and mortality weekly report. 2011;60(41):1424-6.
  10. Munoz FM. Safety of influenza vaccines in pregnant women. American journal of obstetrics and gynecology. 2012;207(3 Suppl):S33-7.
  11. Razzaghi H. Influenza and Tdap vaccination coverage among pregnant women—United States, April 2020. MMWR Morbidity and mortality weekly report. 2020;69.
  12. Lindley MC. Vital signs: burden and prevention of influenza and pertussis among pregnant women and infants—United States. MMWR Morbidity and mortality weekly report. 2019;68.
  13. Properzi S, Carestia R, Birettoni V, Calesso V, Marinelli B, Scapicchi E, et al. Vaccination of pregnant women: an overview of European policies and strategies to promote it. Frontiers in public health. 2024;12:1455318.
  14. Larson HJ, de Figueiredo A, Xiahong Z, Schulz WS, Verger P, Johnston IG, et al. The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey. EBioMedicine. 2016;12:295-301.
  15. Gkentzi D, Katsakiori P, Marangos M, Hsia Y, Amirthalingam G, Heath PT, et al. Maternal vaccination against pertussis: a systematic review of the recent literature. Archives of disease in childhood Fetal and neonatal edition. 2017;102(5):F456-F63.
  16. Neofytou A. Knowledg, Attitudes and Practices of pregnant women regarding maternal pertussis immunization during pregnancy and prevention of congenital infections in Greece, 2019.
  17. Gkentzi D, Zorba M, Marangos M, Vervenioti A, Karatza A, Dimitriou G. Antenatal vaccination for influenza and pertussis: a call to action. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 2021;41(5):750-4.
  18. Saw SM, Ng TP. The design and assessment of questionnaires in clinical research. Singapore medical journal. 2001;42(3):131-5.
  19. Taber KS. The Use of Cronbach’s Alpha When Developing and Reporting Research Instruments in Science Education. Research in Science Education. 2018;48(6):1273-96.
  20. Homer CSE, Javid N, Wilton K, Bradfield Z. Vaccination in pregnancy: The role of the midwife. Frontiers in global women's health. 2022;3:929173.
  21. Bharj KK, Luyben A, Avery MD, Johnson PG, Barger MK, Bick D. An agenda for midwifery education: advancing the state of the world׳ s midwifery. Midwifery. 2016;33:3-6.
  22. Taskou C, Sarantaki A. Knowledge and Attitudes of Healthcare Professionals Regarding Perinatal Influenza Vaccination during the COVID-19 Pandemic. 2023;11(1).
  23. MacDougall DM, Halperin SA. Improving rates of maternal immunization: challenges and opportunities. Human vaccines & immunotherapeutics. 2016;12(4):857-65.
  24. Munoz FM, Jamieson DJ. Maternal immunization. Obstetrics & Gynecology. 2019;133(4):739-53.
  25. Kilich E, Dada S, Francis MR, Tazare J, Chico RM, Paterson P, et al. Factors that influence vaccination decision-making among pregnant women: A systematic review and meta-analysis. PloS one. 2020;15(7):e0234827.
  26. Wiley KE, Massey PD, Cooper SC, Wood NJ, Ho J, Quinn HE, et al. Uptake of influenza vaccine by pregnant women: a cross-sectional survey. Medical Journal of Australia. 2013;198(7):373-5.
  27. Yuen CYS, Tarrant M. Determinants of uptake of influenza vaccination among pregnant women–a systematic review. Vaccine. 2014;32(36):4602-13.
  28. Alhendyani F, Jolly K, Jones LL. Views and experiences of maternal healthcare providers regarding influenza vaccine during pregnancy globally: A systematic review and qualitative evidence synthesis. PloS one. 2022;17(2):e0263234.
  29. Lutz CS, Carr W, Cohn A, Rodriguez L. Understanding barriers and predictors of maternal immunization: Identifying gaps through an exploratory literature review. Vaccine. 2018;36(49):7445-55.
  30. Webb H, Street J, Marshall H. Incorporating immunizations into routine obstetric care to facilitate Health Care Practitioners in implementing maternal immunization recommendations. Human vaccines & immunotherapeutics. 2014;10(4):1114-21.
  31. Khalil A, Samara A, Campbell H, Ladhani SN, Amirthalingam G. Recent increase in infant pertussis cases in Europe and the critical importance of antenatal immunizations: We must do better…now. International Journal of Infectious Diseases. 2024;146:107148.
  32. Principi N, Bianchini S, Esposito S. Pertussis Epidemiology in Children: The Role of Maternal Immunization. Vaccines. 2024;12(9):1030.
  33. European Centre for Disease Prevention and Control. Increase of pertussis cases in the EU/EEA, 8 May 2024. Stockholm: ECDC; 2024. © European Centre for Disease Prevention and Control, Stockholm, 2024. Catalogue number: TQ-02-24-500-EN-N, ISBN: 978-92-9498-717-4, DOI: 10.2900/831122.
Figure 1. Descriptive analysis depicted as % rates of the maternal attitudes regarding influenza and pertussis vaccinations.
Figure 1. Descriptive analysis depicted as % rates of the maternal attitudes regarding influenza and pertussis vaccinations.
Preprints 148670 g001
Figure 2. Level of trust reported by new mothers in different sources of information in vaccine-related issues.
Figure 2. Level of trust reported by new mothers in different sources of information in vaccine-related issues.
Preprints 148670 g002
Table 1. Maternal characteristics.
Table 1. Maternal characteristics.
Characteristic N (%)
Maternal age (groups)
<25 21 (4.6%)
25-29 73 (16.0%)
30-34 143 (31.4%)
>=35 218 (47.9%)
Nationality
Greek 395 (84.2%)
Other 74 (15.8%)
Number of children
1 184 (44.2%)
2 183 (44.0%)
3 40 (9.6%)
4 8 (1.9%)
5 1 (0.2%)
Season of labor
Winter 103 (23.2%)
Spring 113 (25.4%)
Summer 114 (25.6%)
Autumn 115 (25.8%)
Living region
Athens 169 (37.2%)
Another Greek city 177 (39.2%)
Another Greek town 107 (23.6%)
Family state
Unmarried 28 (6.0%)
Married/cohabitation agreement 435 (92.5%)
Divorced/Estranged 7 (1.5%)
Insurance
No 17 (3.6%)
Yes 451 (96.4%)
Are you considered a high-risk group;
No 414 (97.6%)
Yes 10 (2.4%)
Maternal education level
School graduate 146 (36.7%)
Technical school graduate 81 (20.6%)
University graduate 93 (23.5%)
MSc/PhD§ 76 (19.2%)
Mother’s profession
Public worker 73 (15.4%)
Private worker 203 (42.9%)
Free lancer 70 (14.8%)
Unemployed 56 (11.8%)
Other 71 (15.1%)
Healthcare practicioner’s (HCP’s) recommendation regarding influenza vaccination during pregnancy
No 146 (31.1%)
Yes 324 (68.9%)
HCP’s recommendation regarding influenza vaccination during pregnancy
No 341 (72.9%)
Yes 127 (27.1%)
Knowledge score N=439
Mean [Standard Deviation (SD)] 7 (2)
Median [Interquartile Range (IQR)] 8 (7-9)
Min-Max 0-9
Knowledge score (categories)
Low/Intermediate 106 (24.3%)
High 331 (75.7%)
§MSc: Master of Science; PhD: Doctor of Philosophy.
Table 2. Descriptive analysis and crude logistic regression regarding influenza maternal immunization.
Table 2. Descriptive analysis and crude logistic regression regarding influenza maternal immunization.
Vaccine uptake during pregnancy Crude Logistic Adjusted Logistic
Odds Ration (OR) [95% Confidence Intervals (CI)] OR (95% CI) p-value
Infant’s age 1.33 (0.96-1.83) - -
Mean (SD) and Median (IQR) for Women with no Vaccine Uptake (n=214) 0.7 (0.6) and 0.5 (0.2-0.9) - - -
Mean (SD) and Median (IQR) for Women with Vaccine Uptake (n=187) 0.8 (0.6) and 0.7 (0.3-1.0) - - -
n (%)
Maternal age (groups)
<25 5 (23.8%) 1 1 -
25-29 27 (37.0%) 1.88 (0.62-5.70) 1.55 (0.30-7.99) 0.603
30-34 74 (52.1%) 3.48 (1.21-10.02)* 2.35 (0.48-11.57) 0.292
>=35 104 (48.1%) 2.97 (1.05-8.40)* 1.24 (0.26-5.97) 0.793
Nationality
Greek 193 (49.2%) 2.57 (1.48-4.46)* 1.00 (0.41-2.45) 0.998
Other 20 (27.4%) 1 1
Number of children
1 82 (45.3%) 1 - -
2 92 (50.3%) 1.22 (0.81-1.84) - -
>=3 17 (34.7%) 0.64 (0.33-1.24) - -
Season of labor
Winter 50 (48.5%) 1 1 -
Spring 65 (58.6%) 2.29 (1.03-5.07)* 2.29 (1.03-5.07) 0.042
Summer 49 (43.0%) 0.95 (0.45-2.03) 0.95 (0.45-2.03) 0.900
Autumn 40 (35.4%) 0.59 (0.27-1.29) 0.59 (0.27-1.29) 0.189
Living region
Athens 85 (50.9%) 1 -
Another Greek city 75 (42.6%) 0.72 (0.47-1.10) - -
Another Greek town 47 (43.9%) 0.76 (0.46-1.23) - -
Family state
Unmarried 7 (25.0%) 1 1
Married/cohabitation agreement 204 (47.2%) 2.68 (1.12-6.45)* 0.73 (0.18-2.92) 0.660
Divorced/Estranged 3 (42.9%) 2.25 (0.40-12.62) 1.17 (0.10-14.32) 0.904
Insurance
No 2 (11.8%) 1 1
Yes 212 (47.0%) 6.65 (1.50-29.43)* 1.27 (0.17-9.40) 0.814
Are you considered a high-risk group;
No 183 (44.5%) 1 - -
Yes 7 (70.0%) 2.91 (0.74-11.40) - -
Maternal education level
School graduate 55 (38.2%) 1 1
Technical school graduate 34 (41.5%) 1.15 (0.66-1.99) 1.33 (0.58-3.04) 0.495
University graduate 53 (42.7%) 1.21 (0.74-1.97) 0.98 (0.46-2.10) 0.958
MSc/PhD§ 73 (64.6%) 2.95 (1.77-4.93)* 2.93 (1.23-7.00) 0.015
Paternal education level
School graduate 77 (36.8%) 1 - -
Technical school graduate 41 (50.6%) 1.76 (1.05-2.95)* - -
University graduate 51 (54.8%) 2.08 (1.27-3.42)* - -
MSc/PhD§ 42 (56.8%) 2.25 (1.31-3.86)* - -
Mother’s profession
Public worker 42 (57.5%) 1 1
Private worker 92 (45.8%) 0.62 (0.36-1.07) 0.48 (0.21-1.06) 0.071
Free lancer 31 (44.9%) 0.60 (0.31-1.17) 0.86 (0.31-2.39) 0.775
Unemployed 24 (43.6%) 0.57 (0.28-1.16) 0.94 (0.31-2.93) 0.922
Other 25 (35.2%) 0.40 (0.20-0.79)* 0.91 (0.30-2.71) 0.864
Father’s profession
Public worker 39 (58.2%) 1 - -
Private worker 107 (46.3%) 0.62 (0.36-1.07) - -
Free lancer 56 (40.9%) 0.50 (0.27-0.90)* - -
Other 8 (32.0%) 0.34 (0.13-0.89)* - -
HCP’s recommendation regarding influenza vaccination during pregnancy
No 13 (9.0%) 1 1
Yes 201 (62.4%) 16.87 (9.14-31.13)* 18.86 (8.61-41.31) <0.001
Categories Knowledge score
Low/Intermediate 11 (10.4%) 1 - -
High 192 (58.0%) 11.93 (6.16-23.11)* - -
Are you afraid of possible vaccines’ adverse events during pregnancy
No/a little afraid 104 (58.8%) 2.39 (1.63-3.50)* 2.09 (1.18-3.70) 0.012
Fairly afraid/very afraid 108 (37.4%) 1 1
Considering influenza disease dangerous for pregnant women
Non-dangerous/relatively non-dangerous 30 (22.2%) 1 1
Relatively dangerous/ Very dangerous 185 (55.4%) 4.35 (2.74-6.88)* 8.05 (3.81-17.03) <0.001
Considering influenza disease dangerous for infants
Non-dangerous/relatively non-dangerous 9 (18.0%) 1 1
Relatively dangerous/ Very dangerous 206 (49.2%) 4.41 (2.09-9.29)* 0.89 (0.29-2.72) 0.838
Considering influenza vaccine dangerous for pregnant women
Non-dangerous/relatively non-dangerous 185 (55.9%) 4.43 (2.80-7.03)* 4.37 (2.27-8.41) <0.001
Relatively dangerous/ Very dangerous 30 (22.2%) 1 1
*statistically different OR from that of reference category (p<0.05). §MSc: Master of Science; PhD: Doctor of Philosophy. #not included in the multiple logistic model due to multicollinearity with other factors in the model (sub-questions of knowledge score).
Table 3. Descriptive analysis and crude logistic regression regarding pertussis maternal immunization.
Table 3. Descriptive analysis and crude logistic regression regarding pertussis maternal immunization.
Vaccine uptake during pregnancy Crude Logistic Adjusted Logistic
OR (95% CI) OR (95% CI) p-value
Infant’s age 0.85 (0.54-1.35) - -
Mean (SD) and Median (IQR) for Women with no Vaccine Uptake (n=214) 0.7 (0.6) and 0.6 (0.3-1.0) - - -
Mean (SD) and Median (IQR) for Women with Vaccine Uptake (n=187) 0.7 (0.5) and 0.6 (0.3-0.9) - - -
n (%)
Maternal age (groups)
<25 4 (21.0%) 1 - -
25-29 10 (13.9%) 0.60 (0.17-2.20) - -
30-34 29 (20.4%) 0.96 (0.30-3.12) - -
>=35 32 (14.9%) 0.66 (0.21-2.11) - -
Nationality
Greek 68 (17.5%) 1.31 (0.64-2.69) - -
Other 10 (13.9%) 1 - -
Number of children
1 38 (21.2%) 1 1
2 23 (12.7%) 0.54 (0.31-0.95)* 0.55 (0.27-1.14) 0.111
>=3 6 (12.2%) 0.52 (0.21-1.31) 0.52 (0.17-1.62) 0.261
Season of labor
Winter 19 (18.6%) 1.20 (0.59-2.43) - -
Spring 19 (17.3%) 1.09 (0.54-2.21) - -
Summer 17 (14.9%) 0.92 (0.45-1.88) - -
Autumn 18 (16.1%) 1 - -
Living region
Athens 29 (17.6%) 1 - -
Another Greek city 35 (20.1%) 1.18 (0.68-2.04) - -
Another Greek town 12 (11.3%) 0.60 (0.29-1.23) - -
Family state
Unmarried 3 (10.7%) - - -
Married/cohabitation agreement 75 (17.6%) - - -
Divorced/Estranged 0 (0.0%) - - -
Insurance
No 0 (0.0%) - - -
Yes 78 (17.4%) - - -
Are you considered a high-risk group;
No 66 (16.2%) 1 - -
Yes 1 (10.0%) 0.57 (0.07-4.61) - -
Maternal education level
School graduate 19 (13.4%) 1 - -
Technical school graduate 19 (23.5%) 1.98 (0.98-4.02) - -
University graduate 19 (15.3%) 1.17 (0.59-2.33) - -
MSc/PhD§ 21 (18.7%) 1.49 (0.76-2.94) - -
Paternal education level
School graduate 32 (15.4%) 1 - -
Technical school graduate 16 (20.0%) 1.38 (0.71-2.67) - -
University graduate 17 (18.5%) 1.25 (0.65-2.38) - -
MSc/PhD§ 12 (16.4%) 1.08 (0.52-2.23) - -
Mother’s profession
Public worker 9 (12.7%) 1 - -
Private worker 38 (19.0%) 1.62 (0.74-3.54) - -
Free lancer 10 (14.5%) 1.17 (0.44-3.08) - -
Unemployed 10 (18.9%) 1.60 (0.60-4.27) - -
Other 11 (15.5%) 1.26 (0.49-3.26) - -
Father’s profession
Public worker 13 (19.4%) 1 - -
Private worker 39 (17.2%) 0.86 (0.43-1.73) - -
Free lancer 21 (15.3%) 0.75 (0.35-1.61) - -
Unemployed 4 (16.7%) 0.83 (0.24-2.85) - -
Other 13 (19.4%) 1 - -
HCP’s recommendation regarding pertussis vaccination during pregnancy
No 14 (4.2%) 1 1
Yes 64 (52.0%) 25.03 (13.18-47.53) 29.55 (14.11-61.92) <0.001*
Categories Knowledge score
Low/Intermediate 4 (3.8%) 1
High 71 (21.6%) 6.95 (2.47-19.52)*
Are you afraid of possible vaccines’ adverse events during pregnancy
No/a little afraid 38 (21.6%) 1.74 (1.06-2.84)* 1.85 (0.93-3.67) 0.081
Fairly afraid/very afraid 39 (13.7%) 1 1
Considering pertussis disease dangerous for pregnant women
Non-dangerous/relatively non-dangerous 5 (5.1%) 1 1
Relatively dangerous/ Very dangerous 73 (20.2%) 4.71 (1.85-12.02)* 6.00 (1.89-19.05) 0.002*
Considering pertussis disease dangerous for infants
Non-dangerous/relatively non-dangerous 3 (7.3%) 1 - -
Relatively dangerous/ Very dangerous 75 (17.9%) 2.77 (0.83-9.21) - -
Considering pertussis vaccine dangerous for pregnant women
Non-dangerous/relatively non-dangerous 61 (19.1%) 1.72 (0.97-3.08) - -
Relatively dangerous/ Very dangerous 17 (12.1%) 1 - -
*statistically different OR from that of reference category (p<0.05) . §MSc: Master of Science; PhD: Doctor of Philosophy. #not included in the multiple logistic model due to multicollinearity with other factors in the model (sub-questions of knowledge score).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated